ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 85 filers reported holding ONCOMED PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $96,000 | +50.0% | 21,195 | +9.8% | 0.00% | 0.0% |
| Q2 2017 | $64,000 | -68.8% | 19,312 | -13.2% | 0.00% | -50.0% |
| Q1 2017 | $205,000 | -4.7% | 22,240 | -20.3% | 0.00% | 0.0% |
| Q4 2016 | $215,000 | -25.9% | 27,913 | +9.9% | 0.00% | -50.0% |
| Q3 2016 | $290,000 | -4.6% | 25,395 | +2.8% | 0.00% | 0.0% |
| Q2 2016 | $304,000 | +23.6% | 24,695 | +1.4% | 0.00% | +33.3% |
| Q1 2016 | $246,000 | -59.1% | 24,357 | -8.7% | 0.00% | -57.1% |
| Q4 2015 | $601,000 | +47.7% | 26,677 | +8.7% | 0.01% | +16.7% |
| Q3 2015 | $407,000 | -30.8% | 24,543 | -6.0% | 0.01% | -25.0% |
| Q2 2015 | $588,000 | -13.9% | 26,119 | -1.4% | 0.01% | 0.0% |
| Q1 2015 | $683,000 | +39.7% | 26,478 | +17.8% | 0.01% | +33.3% |
| Q4 2014 | $489,000 | +27.0% | 22,473 | +10.4% | 0.01% | +20.0% |
| Q3 2014 | $385,000 | -31.5% | 20,359 | -15.5% | 0.01% | -28.6% |
| Q2 2014 | $562,000 | -38.7% | 24,100 | -11.6% | 0.01% | -36.4% |
| Q1 2014 | $917,000 | +147.2% | 27,262 | +116.7% | 0.01% | +83.3% |
| Q4 2013 | $371,000 | – | 12,578 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|